Dr. Daniel E. Nixon, DO

Dr. Nixon practices at VCU Medical Center Main Hospital in Bedford, New Hampshire.

Dr. Nixon's NPI, 1255417291, was assigned on October 31, 2006. Dr. Nixon holds Virginia license 0102037226.

Dr. Nixon's primary practice is VCU Medical Center Main Hospital, at 8 Technology Dr, Bedford, NH 03110 in Hillsborough County. The practice phone is (804) 221-1067.

Dr. Nixon's primary practice is VCU Medical Center Main Hospital in Bedford, New Hampshire.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nixon practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Nixon's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nixon is licensed in Virginia.

CMS data shows 51 Medicare services from Dr. Nixon across 2 procedure codes in 2024, for 56 Medicare patients. Medicare paid $3,577 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Dr. Nixon in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nixon's median patient age at 39, with 33% women.

In 2024, Dr. Nixon wrote 1,668 Medicare Part D claims for 99 patients. 33% of them were for generic drugs. CMS names the drug for 1,485 of them, across 33 drugs with 11 or more claims each, at $3,231,762 in total drug cost. In 2023, CMS named 1,671 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Nixon for performance year 2024, reported as part of a group.

Dmand AI links 22 papers to Dr. Nixon, published from 2012 to 2025. 2016 was the busiest year, with 4. The most frequent topics are HIV Infections, Anti-HIV Agents and Inflammation. Dr. Nixon has published most often in AIDS. Dr. Nixon's most frequent co-authors are Judith Ann Aberg, MD, Daniel A. Duprez, MD and Ken M. Kunisaki, MD.

Dmand AI links Dr. Nixon to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Severe Acute Respiratory Syndrome, Influenza, Human and HIV Infections. University of Minnesota sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Nixon from 2 drug and device companies from 2018 to 2020. Food and beverage make up the largest share, 79% of the total. ViiV Healthcare Company paid the most, $49.